COMMUNIQUÉS West-GlobeNewswire

Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD
20/09/2018
ADVM-022 is a unique single-administration gene therapy delivered intravitreally for the treatment of wAMD OPTIC Phase 1 clinical trial initiation expected in 4Q18 MENLO PARK, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- [...]
Precision Optics Corporation Schedules Fiscal Year End Conference Call
19/09/2018
GARDNER, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") announced that it intends to release its financial results for the fiscal year ended June 30, 2018 [...]
Healthcare Special Opportunities Fund Announces September 2018 Quarterly Distribution
19/09/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- ( TSX: MDS.UN ) – LDIC Inc. (the “ Manager ”), the manager of Healthcare Special [...]
Spectrum Health & Human Services Selects Cerner to Support Improved Behavioral Health Care Delivery
19/09/2018
ORCHARD PARK, N.Y., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Spectrum Health & Human Services has selected Cerner, a global leader in health care technology, to implement an electronic health record (EHR) and revenue [...]
Veritas’ Cannevert to Offer Testing Services for Cannabis & Hemp Licensed Producers; Corporate Update
19/09/2018
VANCOUVER, British Columbia, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to provide a corporate update on its activities, [...]
Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018
19/09/2018
COPENHAGEN, Denmark, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We”, “Forward” or the “Company” and together with its subsidiaries, the “Group”), today reported consolidated financial results [...]
TESARO Announces Participation at Two Investor Conferences
19/09/2018
WALTHAM, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]
CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
19/09/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]
Integra LifeSciences to participate in the Cantor Global Healthcare Conference
19/09/2018
PLAINSBORO, N.J., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in October [...]
Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock
19/09/2018
AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage oncology company focused on the discovery and development of proprietary [...]
Oncolytics Biotech® Provides Corporate and Clinical Update
19/09/2018
- Webcast and conference call for investors and analysts on Thursday, September 20 at 8:30 a.m. EDT - CALGARY, Alberta and SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC) (NASDAQ: ONCY [...]
CherryCircle Software Inc. Releases QbDVision™ for Pharmaceutical Process Development and Manufacturing
19/09/2018
AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- CherryCircle Software, Inc., a software company developing novel solutions for the pharmaceutical manufacturing industry, announced the Americana release of its [...]
Colibri Heart Valve to Present Patient Follow-up Results from Clinical Feasibility Study of Second-Generation TAVI System at TCT
19/09/2018
BROOMFIELD, CO , Sept. 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that results from the company’s international, single-arm, open-label early [...]
Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018
19/09/2018
DANVERS, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), the leader in heart recovery, announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (TCT) conference will [...]
SPINEWAY : Early redemption of 44 ORNANE Notes End of bond financing by ORNANE
19/09/2018
Press release Ecully, 19 September 2018 Early redemption of 44 " ORNANE " Notes End of bond financing ( ORNANE ) Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column ( [...]
SPINEWAY : Remboursement anticipé de 44 ORNANE Fin du financement obligataire par ORNANE
19/09/2018
Communiqué de presse Ecully, le 19 septembre 2018 Remboursement anticipé de 44 ORNANE Fin du financement obligataire (ORNANE) Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des [...]
SIA Again Names The Delta Companies One of the Largest Staffing Firms in the U.S. for 2018
19/09/2018
From year to year, the firm continues on a steady growth trajectory DALLAS, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The Delta Companie s (TDC) , a leading staffing firm for healthcare professionals nationwide, has once again [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
19/09/2018
FIT Biotech Oy Company release September 19, 2018 at 06:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights
19/09/2018
The Chairman Hans Peter Bøhn has today, 19 September 2018, subscribed for 40,106 new shares in PCI Biotech Holding ASA (the "Company") at a subscription price of NOK 30 per share by exercising all his 40,106 [...]

Pages